Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exercise physiology in cardiovascular diseases.

W R Hiatt1

  • 1University of Colorado, Denver.

Current Opinion in Cardiology
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Toxicity of a novel therapeutic agent targeting mitochondrial complex I.

Clinical pharmacology and therapeutics·2015
Same author

Response to ‘Statement from the European Society of Vascular Surgery and the World Federation of Vascular Surgery Societies’ Inter-Society Consensus Document (TASC) III and International Standards for Vascular Care (ISVaC).

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2014
Same author

Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events.

European journal of preventive cardiology·2013
Same author

Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach.

Journal of thrombosis and haemostasis : JTH·2013
Same author

Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?

Journal of thrombosis and haemostasis : JTH·2012

Exercise rehabilitation programs for peripheral arterial disease and congestive heart failure are now well-developed. These programs improve exercise performance and quality of life through peripheral adaptations, not cardiac changes.

Area of Science:

  • Cardiology
  • Rehabilitation Medicine
  • Exercise Physiology

Background:

  • Established exercise protocols exist for myocardial infarction and coronary artery bypass surgery recovery.
  • Exercise rehabilitation programs for peripheral arterial disease (PAD) and congestive heart failure (CHF) with left ventricular dysfunction are less developed.
  • Recent advancements provide reproducible exercise testing protocols for PAD and CHF patients.

Purpose of the Study:

  • To outline the development and efficacy of exercise rehabilitation programs for patients with PAD and CHF.
  • To investigate the impact of these programs on exercise capacity and quality of life.
  • To elucidate the underlying mechanisms of improvement in exercise performance.

Main Methods:

  • Utilizing reproducible exercise testing protocols with objective performance measures for PAD and CHF patients.

Related Experiment Videos

  • Defining changes in exercise capacity based on established testing methods.
  • Implementing structured exercise training programs.
  • Main Results:

    • Exercise training programs significantly increase exercise performance in PAD and CHF patients.
    • Improvements in community-based quality of life were observed.
    • The primary mechanism of improvement appears to be peripheral adaptations in skeletal muscle metabolism.

    Conclusions:

    • Exercise rehabilitation is effective for patients with PAD and CHF.
    • Improvements are driven by peripheral skeletal muscle adaptations, not enhanced cardiac output or blood flow.
    • These findings support the development of standardized exercise programs for these patient populations.